111 related articles for article (PubMed ID: 9989838)
1. Different regulation of c-Myc- and E2F-1-induced apoptosis during the ongoing cell cycle.
Hengstschläger M; Hölzl G; Hengstschläger-Ottnad E
Oncogene; 1999 Jan; 18(3):843-8. PubMed ID: 9989838
[TBL] [Abstract][Full Text] [Related]
2. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
3. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
5. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells.
Yang HL; Dong YB; Elliott MJ; Liu TJ; McMasters KM
Clin Cancer Res; 2000 Apr; 6(4):1579-89. PubMed ID: 10778992
[TBL] [Abstract][Full Text] [Related]
6. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
7. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis.
Shan B; Farmer AA; Lee WH
Cell Growth Differ; 1996 Jun; 7(6):689-97. PubMed ID: 8780882
[TBL] [Abstract][Full Text] [Related]
8. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of E2F-1 induces cyclin A- and E-associated kinase activities independently from cell cycle position.
Soucek T; Pusch O; Hengstschläger-Ottnad E; Adams PD; Hengstschläger M
Oncogene; 1997 May; 14(19):2251-7. PubMed ID: 9178900
[TBL] [Abstract][Full Text] [Related]
10. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.
Ishida S; Shudo K; Takada S; Koike K
Cell Growth Differ; 1995 Mar; 6(3):229-37. PubMed ID: 7794791
[TBL] [Abstract][Full Text] [Related]
11. p27kip1-independent cell cycle regulation by MYC.
Berns K; Martins C; Dannenberg JH; Berns A; te Riele H; Bernards R
Oncogene; 2000 Oct; 19(42):4822-7. PubMed ID: 11039898
[TBL] [Abstract][Full Text] [Related]
12. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
Alesse E; Zazzeroni F; Angelucci A; Giannini G; Di Marcotullio L; Gulino A
Cell Death Differ; 1998 May; 5(5):381-9. PubMed ID: 10200487
[TBL] [Abstract][Full Text] [Related]
13. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
Ahmad N; Gupta S; Mukhtar H
Oncogene; 1999 Mar; 18(10):1891-6. PubMed ID: 10086343
[TBL] [Abstract][Full Text] [Related]
14. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation.
Strom DK; Cleveland JL; Chellappan S; Nip J; Hiebert SW
Cell Growth Differ; 1998 Jan; 9(1):59-69. PubMed ID: 9438389
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
[TBL] [Abstract][Full Text] [Related]
17. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
Elliott MJ; Dong YB; Yang H; McMasters KM
Clin Cancer Res; 2001 Nov; 7(11):3590-7. PubMed ID: 11705881
[TBL] [Abstract][Full Text] [Related]
18. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP
Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions.
Lind EF; Wayne J; Wang QZ; Staeva T; Stolzer A; Petrie HT
J Immunol; 1999 May; 162(9):5374-9. PubMed ID: 10228014
[TBL] [Abstract][Full Text] [Related]
20. Caspase-dependent apoptosis by ectopic expression of E2F-4.
Chang YC; Nakajima H; Illenye S; Lee YS; Honjo N; Makiyama T; Fujiwara I; Mizuta N; Sawai K; Saida K; Mitsui Y; Heintz NH; Magae J
Oncogene; 2000 Sep; 19(41):4713-20. PubMed ID: 11032021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
